Phio Pharmaceuticals
PHIO
#10279
Rank
C$17.33 M
Marketcap
C$1.57
Share price
-2.56%
Change (1 day)
-60.59%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -C$9.89 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -C$9.85 Million, an increase over its 2023 earnings that were of -C$14.91 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -C$9.89 Million0.42%
2024 -C$9.85 Million-33.96%
2023 -C$14.91 Million-5.7%
2022 -C$15.81 Million-13.6%
2021 -C$18.3 Million51.09%
2020 -C$12.11 Million-1.28%
2019 -C$12.27 Million21.03%
2018 -C$10.14 Million-53.1%
2017 -C$21.62 Million74.49%
2016 -C$12.39 Million-12.02%
2015 -C$14.08 Million16.17%
2014 -C$12.12 Million-57.95%
2013 -C$28.82 Million62.45%
2012 -C$17.74 Million0.87%
2011 -C$17.59 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-C$25.01 Million 156.26%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-C$0.22 Billion 2,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA